MRC Translational Immune Discovery Unit
T cell responses to monkeypox play a part in protecting against infection
A new study, led by researchers at the MRC TIDU in the MRC Weatherall Institute of Molecular Medicine, NDM's CAMS Oxford Institute, the Centre for Human Genetics, the Kennedy Institute and the Dunn School of Pathology, has found that specific T cells could have an impact on the long-term protective responses to future infection.
Read moreAt the MRC Translational Immune Discovery Unit we pioneer the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases. We innovate some of our leading discoveries to create new medicines.
The MRC TIDU consists of 13 research teams with over 130 scientists. We define the unknown in human immune pathogenesis for the benefit of patients.
©
Kateryna Kon
©
Eric Sezgin
Collaboration and innovation lie at the heart of the MRC TIDU. Our research groups work together to understand how the human immune system functions, what happens when it fails, and how we can use our knowledge of these systems to improve patient outcomes. By working together with clinicians, industry and charities, we aim to translate our scientific findings at the TIDU so that they can have a positive impact on global health.
- Professor Alison Simmons
